Subclinical hypothyroidism and survival: the effects of heart failure and race

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 6, 2013, Pages 2326-2336

  Rhee, Connie M ^a,b   Curhan, Gary C ^a,b,c   Alexander, Erik K ^a,b   Bhan, Ishir ^b,d   Brunelli, Steven M ^a,b,e  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e DAVITA CLINICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THYROXINE;

ADULT; AFRICAN AMERICAN; ARTICLE; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE ASSOCIATION; EUTHYROIDISM; FEMALE; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RACE DIFFERENCE; RETROSPECTIVE STUDY; SUBCLINICAL HYPOTHYROIDISM; SURVIVAL RATE; THYROXINE BLOOD LEVEL;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; ATHEROSCLEROSIS; COHORT STUDIES; FEMALE; HEART FAILURE; HUMANS; HYPOTHYROIDISM; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84878494283     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-1039     Document Type: Article

References (44)

1. 4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87(2):489-499.
2. McDermott MT Overview of the clinical manifestations of hypothyroidism. In: Braverman LE, Cooper DS, eds. Werner and Ingbar's The Thyroid. 10th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2013:569-575.
3. Cooper DS, Biondi B. Subclinical thyroid disease. Lancet. 2012;379(9821):1142-1154.
4. Thvilum M, Brandt F, Brix TH, Hegedüs L. Areview of the evidence for and against increased mortality in hypothyroidism. Nat Rev Endocrinol. 2012;8(7):417-424.
5. Boekholdt SM, Titan SM, Wiersinga WM, et al. Initial thyroid status and cardiovascular risk factors: the EPIC-Norfolk prospective population study. Clin Endocrinol (Oxf). 2010;72(3):404-410.
6. Cappola AR, Fried LP, Arnold AM, et al. Thyroid status, cardiovascular risk, and mortality in older adults. JAMA. 2006;295(9):1033-1041.
7. de Jongh RT, Lips P, van Schoor NM, et al. Endogenous subclinical thyroid disorders, physical and cognitive function, depression, and mortality in older individuals. Eur J Endocrinol. 2011;165(4):545-554.
8. Gussekloo J, van Exel E, de Craen AJ, Meinders AE, Frölich M, Westendorp RG. Thyroid status, disability and cognitive function, and survival in old age. JAMA. 2004;292(21):2591-2599. (Pubitemid 39577515)
9. Iervasi G, Molinaro S, Landi P, et al. Association between increased mortality and mild thyroid dysfunction in cardiac patients. Arch Intern Med. 2007;167(14):1526-1532. (Pubitemid 47124183)
10. Imaizumi M, Akahoshi M, Ichimaru S, et al. Risk for ischemic heart disease and all-cause mortality in subclinical hypothyroidism. J Clin Endocrinol Metab. 2004;89(7):3365-3370. (Pubitemid 38951905)
11. McQuade C, Skugor M, Brennan DM, Hoar B, Stevenson C, Hoogwerf BJ. Hypothyroidism and moderate subclinical hypothyroidism are associated with increased all-cause mortality independent of coronary heart disease risk factors: a PreCIS database study. Thyroid. 2011;21(8):837-843.
12. Molinaro S, Iervasi G, Lorenzoni V, et al. Persistence of mortality risk in patients with acute cardiac diseases and mild thyroid dysfunction. Am J Med Sci. 2012;343(1):65-70.
13. Razvi S, Weaver JU, Vanderpump MP, Pearce SH. The incidence of ischemic heart disease and mortality in people with subclinical hypothyroidism: reanalysis of the Whickham Survey cohort. J Clin Endocrinol Metab. 2010;95(4):1734-1740.
14. Rodondi N, Newman AB, Vittinghoff E, et al. Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Arch Intern Med. 2005;165(21):2460-2466. (Pubitemid 41720006)
15. Sgarbi JA, Matsumura LK, Kasamatsu TS, Ferreira SR, Maciel RM. Subclinical thyroid dysfunctions are independent risk factors for mortality in a 7.5-year follow-up: the Japanese-Brazilian thyroid study. Eur J Endocrinol. 2010;162(3):569-577.
16. Walsh JP, Bremner AP, Bulsara MK, et al. Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. Arch Intern Med. 2005;165(21):2467-2472. (Pubitemid 41720007)
17. Waring AC, Harrison S, Samuels MH, et al Osteoporotic Fractures in Men (MrOS) Study. Thyroid function and mortality in older men: a prospective study. J Clin Endocrinol Metab. 2012;97(3):862-870.
18. Rodondi N, den Elzen WP, Bauer DC, et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA. 2010;304(12):1365-1374.
19. Gencer B, Collet TH, Virgini V, et al. Subclinical thyroid dysfunction and the risk of heart failure events: an individual participant data analysis from 6 prospective cohorts. Circulation. 2012;126(9):1040-1049.
20. Cini G, Carpi A, Mechanick J, et al. Thyroid hormones and the cardiovascular system: pathophysiology and interventions. Biomed Pharmacother. 2009;63(10):742-753.
21. Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med. 2001;344(7):501-509. (Pubitemid 32164903)
22. Mann DL Pathophysiology of heart failure. In: Bonow RO, Mann DL, Zipes DP, Libby P, eds. Bonow: Braunwald's Heart Disease-A Textbook of Cardiovascular Medicine. 9th ed. Philadelphia, PA: Elsevier Saunders; 2012:487-504.
23. Ladenson PW Diagnosis of hypothyroidism. In: Braverman LE, Cooper DS, eds. Werner and Ingbar's The Thyroid. 10th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2013:606-611.
24. Bagchi N, Brown TR, Parish RF. Thyroid dysfunction in adults over age 55 years. A study in an urban US community. Arch Intern Med. 1990;150(4):785-787. (Pubitemid 20122054)
25. Boucai L, Surks MI. Reference limits of serum TSH and free T4 are significantly influenced by race and age in an urban outpatient medical practice. Clin Endocrinol (Oxf). 2009;70(5):788-793.
26. Schectman JM, Kallenberg GA, Hirsch RP, Shumacher RJ. Report of an association between race and thyroid stimulating hormone level. Am J Public Health. 1991;81(4):505-506.
27. Walker JA, Illions EH, Huddleston JF, Smallridge RC. Racial comparisons of thyroid function and autoimmunity during pregnancy and the postpartum period. Obstet Gynecol. 2005;106(6):1365-1371. (Pubitemid 41668958)
28. Surks MI, Boucai L. Age- and race-based serum thyrotropin reference limits. J Clin Endocrinol Metab. 2010;95(2):496-502.
29. Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94. Series 1: programs and collection procedures. Vital Health Stat. 1994;1:1-407.
30. Wiersinga WM Hypothyroidism and myxedema coma. In: DeGroot LJ, Jameson JL, eds. Endocrinology. Vol 2. 5th ed. Philadelphia, PA: Elsevier Saunders; 2006:2081-2099.
31. Gunter EW, Lewis BL, Koncikowski SM Laboratory methods used for the Third National Health and Nutrition Examination Survey (NHANES III), 1988-1994. Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Questionnaire (or Examination Protocol, or Laboratory Protocol). Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 1996.
32. Keane WF, Eknoyan G. Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): a position paper of the National Kidney Foundation. Am J Kidney Dis. 1999;33(5):1004-1010. (Pubitemid 29214705)
33. Selvin E, Manzi J, Stevens LA, et al. Calibration of serum creatinine in the National Health and Nutrition Examination Surveys (NHANES) 1988-1994, 1999-2004. Am J Kidney Dis. 2007;50(6):918-926. (Pubitemid 350122815)
34. Levey AS, Stevens LA, Schmid CH, et al. Anew equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604-612.
35. Cooper D, Ladenson PW The thyroid gland. In: Gardner DG, Shoback D, eds. Greenspan's Basic and Clinical Endocrinology. 9th ed. New York, NY: McGraw Hill Medical; 2011:163-226.
36. Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA. 2004;291(2):228-238. (Pubitemid 38082818)
37. Fillenbaum GG, Burchett BM, Blazer DG. Identifying a national death index match. Am J Epidemiol. 2009;170(4):515-518.
38. Anderson RN, Minino AM, Hoyert DL, Rosenberg HM 2001 Comparability of cause of death between ICD-9 and ICD-10: preliminary estimates. Natl Vital Stat Rep. 2001;49(2):1-32.
39. Ginde AA, Scragg R, Schwartz RS, Camargo CA Jr. Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults. J Am Geriatr Soc 2009;57(9):1595-1603.
40. Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med. 2000;132(4):270-278. (Pubitemid 30106257)
41. Galetta F, Franzoni F, Fallahi P, et al. Heart rate variability and QT dispersion in patients with subclinical hypothyroidism. Biomed Pharmacother. 2006;60(8):425-430. (Pubitemid 44428098)
42. Wartofsky L, Dickey RA. The evidence for a narrower thyrotropin reference range is compelling. J Clin Endocrinol Metab. 2005;90(9):5483-5488. (Pubitemid 41262320)
43. Soldin OP Measuring serum thyroid-stimulating hormone, thyroid hormones, thyroid-directed antibodies, and transport proteins. In: Braverman LE, Cooper DS, eds. Werner and Ingbar's The Thyroid. 10th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2013:279-297.
44. Andersen S, Pedersen KM, Bruun NH, Laurberg P. Narrow individual variations in serum T4 and T3 in normal subjects: a clue to the understanding of subclinical thyroid disease. J Clin Endocrinol Metab. 2002;87(3):1068-1072. (Pubitemid 36121067)